DHL Supply Chain, the Americas leader in contract logistics andpart of Deutsche Post DHL Group, is making further investments tostrengthen its life sciences and healthcare capabilities in NorthAmerica. The company today announced that it has committed morethan USD 70 million to develop additional specialized warehousinginfrastructure and deploy new technologies in support of itspharmaceutical and medical devices customers. The latest commitmentbuilds on the USD 150 million investment that DHL Supply Chainannounced in June 2019 to expand its U.S. distribution network forthe industry and bring critical healthcare products closer to tradepartners and patients.
